The structural basis of alpha-tropomyosin linked (Asp230Asn) familial dilated cardiomyopathy

Autor: Lynn, M.L., Tal Grinspan, L., Holeman, T.A., Jimenez, J., Strom, J., Tardiff, J.C.

Publikováno v: In Journal of Molecular and Cellular Cardiology July 2017 108:127-137

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma.

Autor: Ruiz de Galarreta M; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Bresnahan E; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Molina-Sánchez P; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Lindblad KE; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, New York., Maier B; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Sia D; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Puigvehi M; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Hospital del Mar, IMIM, Universitat Autònoma de Barcelona, Barcelona, Spain., Miguela V; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Casanova-Acebes M; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Dhainaut M; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Villacorta-Martin C; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Singhi AD; Division of Experimental Pathology, Department of Pathology, Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Pittsburgh Liver Research Center, University of Pittsburgh Medical Center and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Moghe A; Division of Experimental Pathology, Department of Pathology, Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., von Felden J; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; First Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Tal Grinspan L; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Wang S; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Kamphorst AO; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, New York., Monga SP; Division of Experimental Pathology, Department of Pathology, Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Pittsburgh Liver Research Center, University of Pittsburgh Medical Center and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Brown BD; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, New York., Villanueva A; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, New York., Llovet JM; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Liver Cancer Translational Research Laboratory, Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit and Pathology Department, IDIBAPS, Hospital Clínic, CIBERehd, Universitat de Barcelona, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Merad M; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, New York., Lujambio A; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York. amaia.lujambio@mssm.edu.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, New York.

Publikováno v: Cancer discovery [Cancer Discov] 2019 Aug; Vol. 9 (8), pp. 1124-1141. Date of Electronic Publication: 2019 Jun 11.